The Present And Future Of WeMed Medical

March 25th, 2022, Mr. Yang He, CEO of WeMed Medical, was interviewed by Paking University Alumni Youth CEO Club, and talked about the development story and future plan of WeMed Medical.

WeMed Medical has deeply focusing on Digital Subtraction Angiography System for many years, ranked on the top three in the field of high-end DSA system production and research in China. And ranked on the second of the original invention patents in the field of vascular interventional surgery robots globally.

As a representative of high-end domestic manufacture of medical equipment in China, the products of WeMed include Digital Angiography System, Surgical C-arm system and Interventional Operation Robot. In Yang He's view, WeMed Medical is still at a critical stage of development. There are three main competitiveness: superior resources, focusing on interventional industry and, making achievements in localization. 

WeMed Medical has been starting its global blueprint since 2016. And through international mergers and acquisitions, became the holding company of Eurocolumbus , which is a well-known Italian interventional imaging equipment enterprise with history of 50 years. After several years of development, WeMed has gradually gained share in the international market and has achieved substantial profits.

WeMed Medical will adhere to the principle of the supremacy of life, excellent quality, products localization, meanwhile, develop international markets actively in the future.